世界の末期腎臓病治療市場2019

• 英文タイトル：Global End-Stage Kidney Disease Treatment Sales Market Report 2019

• レポートコード：QYR9N0792
• 出版社/出版日：QYResearch / 2019年6月10日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥592,000 (USD4,000)	▷ お問い合わせ
Enterprise License	￥1,184,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートでは、末期腎臓病治療の世界市場について調査・分析し、末期腎臓病治療のメーカー別販売量、市場シェア分析、種類別販売分析（MK-3866、パクリチニブ、サンギネート、テシドルマブ、その他）、用途別販売分析（診療所、病院、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・末期腎臓病治療市場概要
・末期腎臓病治療のメーカー別販売量・メーカー別シェア
・末期腎臓病治療の種類別販売量（MK-3866、パクリチニブ、サンギネート、テシドルマブ、その他）
・末期腎臓病治療の用途別販売量（診療所、病院、その他）
・末期腎臓病治療の地域別販売量・市場シェア
・末期腎臓病治療の米国市場規模（2014年-2019年）
・末期腎臓病治療のヨーロッパ市場規模（2014年-2019年）
・末期腎臓病治療の中国市場規模（2014年-2019年）
・末期腎臓病治療の日本市場規模（2014年-2019年）
・末期腎臓病治療の東南アジア市場規模（2014年-2019年）
・末期腎臓病治療のインド市場規模（2014年-2019年）
・末期腎臓病治療メーカー分析（企業概要、製品概要、販売量、売上、価格等）
・末期腎臓病治療のコスト分析
・末期腎臓病治療販売チャネル、流通業者、顧客
・末期腎臓病治療の世界市場動向・機会・成長要因・課題
・末期腎臓病治療の種類別世界市場予測（MK-3866、パクリチニブ、サンギネート、テシドルマブ、その他）
・末期腎臓病治療の用途別世界市場予測（診療所、病院、その他）
・末期腎臓病治療の米国市場予測（2019年-2025年）
・末期腎臓病治療のヨーロッパ市場予測（2019年-2025年）
・末期腎臓病治療の中国市場予測（2019年-2025年）
・末期腎臓病治療の日本市場予測（2019年-2025年）
・末期腎臓病治療の東南アジア市場予測（2019年-2025年）
・末期腎臓病治療のインド市場予測（2019年-2025年）
...

The global End-Stage Kidney Disease Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global End-Stage Kidney Disease Treatment market status and forecast, categorizes the global End-Stage Kidney Disease Treatment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
BLR Bio LLC
CTI BioPharma Corp
F. Hoffmann-La Roche Ltd
Novartis AG
Prolong Pharmaceuticals LLC
VESSL Therapeutics Ltd
…

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
MK-3866
Pacritinib
Sanguinate
Tesidolumab
Others

Segment by Application
Clinic
Hospital
Others

レポート目次

Table of Contents

Global End-Stage Kidney Disease Treatment Sales Market Report 2019
1 End-Stage Kidney Disease Treatment Market Overview
1.1 End-Stage Kidney Disease TreatmentProduct Overview
1.2 End-Stage Kidney Disease Treatment Segment by Type
1.2.1 Global End-Stage Kidney Disease Treatment Sales Comparison by Types (2014-2025)
1.2.2 MK-3866
1.2.3 Pacritinib
1.2.4 Sanguinate
1.2.5 Tesidolumab
1.2.6 Others
1.3 End-Stage Kidney Disease Treatment Segment by Application
1.3.1 Global End-Stage Kidney Disease Treatment Sales Comparison by Application (2014-2025)
1.3.1 Clinic
1.3.2 Hospital
1.3.3 Others
1.4 End-Stage Kidney Disease Treatment Market by Region
1.4.1 Global End-Stage Kidney Disease Treatment Revenue Comparison by Region (2014-2025)
1.4.2 United States End-Stage Kidney Disease Treatment Status and Prospect (2014-2025)
1.4.3 Europe End-Stage Kidney Disease Treatment Status and Prospect (2014-2025)
1.4.4 China End-Stage Kidney Disease Treatment Status and Prospect (2014-2025)
1.4.5 Japan End-Stage Kidney Disease Treatment Status and Prospect (2014-2025)
1.4.6 Southeast Asia End-Stage Kidney Disease Treatment Status and Prospect (2014-2025)
1.4.7 India End-Stage Kidney Disease Treatment Status and Prospect (2014-2025)
1.5 Global End-Stage Kidney Disease Treatment Sales and Revenue (2014-2025)
1.5.1 Global End-Stage Kidney Disease Treatment Sales and Growth Rate (2014-2025)
1.5.2 Global End-Stage Kidney Disease Treatment Revenue and Growth Rate (2014-2025)

2 End-Stage Kidney Disease Treatment by Company, Region, Type and Application
2.1 Global End-Stage Kidney Disease Treatment Market Competition by Companies
2.1.1 Global End-Stage Kidney Disease Treatment Sales Market Share of Key Companies (2014-2019)
2.1.2 Global End-Stage Kidney Disease Treatment Revenue Market Share by Company (2014-2019)
2.2 Global End-Stage Kidney Disease Treatment Sales and Revenue by Region
2.2.1 Global End-Stage Kidney Disease Treatment Sales Market Share by Region (2014-2019)
2.2.2 Global End-Stage Kidney Disease Treatment Revenue Market Share by Region (2014-2019)
2.3 Global End-Stage Kidney Disease Treatment Sales and Revenue by Type
2.3.1 Global End-Stage Kidney Disease Treatment Sales Market Share by Type (2014-2019)
2.3.2 Global End-Stage Kidney Disease Treatment Revenue Market Share by Type (2014-2019)
2.4 Global End-Stage Kidney Disease Treatment Sales by Application

3 United States End-Stage Kidney Disease Treatment Sales, Revenue and Price
3.1 United States End-Stage Kidney Disease Treatment Sales and Revenue (2014-2019)
3.1.1 United States End-Stage Kidney Disease Treatment Sales Growth Rate (2014-2019)
3.1.2 United States End-Stage Kidney Disease Treatment Revenue Growth Rate (2014-2019)
3.1.3 United States End-Stage Kidney Disease Treatment Price Trend (2014-2019)
3.2 United States End-Stage Kidney Disease Treatment Sales Market Share by Company
3.3 United States End-Stage Kidney Disease Treatment Sales Market Share by Type
3.4 United States End-Stage Kidney Disease Treatment Sales Market Share by Application

4 Europe End-Stage Kidney Disease Treatment Sales, Revenue and Price
4.1 Europe End-Stage Kidney Disease Treatment Sales and Value (2014-2019)
4.1.1 Europe End-Stage Kidney Disease Treatment Sales Growth Rate (2014-2019)
4.1.2 Europe End-Stage Kidney Disease Treatment Revenue Growth Rate (2014-2019)
4.1.3 Europe End-Stage Kidney Disease Treatment Price Trend (2014-2019)
4.2 Europe End-Stage Kidney Disease Treatment Sales Market Share by Company
4.3 Europe End-Stage Kidney Disease Treatment Sales Market Share by Type
4.4 Europe End-Stage Kidney Disease Treatment Sales Market Share by Application

5 China End-Stage Kidney Disease Treatment Sales, Revenue and Price
5.1 China End-Stage Kidney Disease Treatment Sales and Revenue (2014-2019)
5.1.1 China End-Stage Kidney Disease Treatment Sales Growth Rate (2014-2019)
5.1.2 China End-Stage Kidney Disease Treatment Revenue Growth Rate (2014-2019)
5.1.3 China End-Stage Kidney Disease Treatment Price Trend (2014-2019)
5.2 China End-Stage Kidney Disease Treatment Sales Market Share by Company
5.3 China End-Stage Kidney Disease Treatment Sales Market Share by Type
5.4 China End-Stage Kidney Disease Treatment Sales Market Share by Application

6 Japan End-Stage Kidney Disease Treatment Sales, Revenue and Price
6.1 Japan End-Stage Kidney Disease Treatment Sales and Value (2014-2019)
6.1.1 Japan End-Stage Kidney Disease Treatment Sales Growth Rate (2014-2019)
6.1.2 Japan End-Stage Kidney Disease Treatment Revenue Growth Rate (2014-2019)
6.1.3 Japan End-Stage Kidney Disease Treatment Price Trend (2014-2019)
6.2 Japan End-Stage Kidney Disease Treatment Sales Market Share by Company
6.3 Japan End-Stage Kidney Disease Treatment Sales Market Share by Type
6.4 Japan End-Stage Kidney Disease Treatment Sales Market Share by Application

7 Southeast Asia End-Stage Kidney Disease Treatment Sales, Revenue and Price
7.1 Southeast Asia End-Stage Kidney Disease Treatment Sales and Value (2014-2019)
7.1.1 Southeast Asia End-Stage Kidney Disease Treatment Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia End-Stage Kidney Disease Treatment Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia End-Stage Kidney Disease Treatment Price Trend (2014-2019)
7.2 Southeast Asia End-Stage Kidney Disease Treatment Sales Market Share by Company
7.3 Southeast Asia End-Stage Kidney Disease Treatment Sales Market Share by Type
7.4 Southeast Asia End-Stage Kidney Disease Treatment Sales Market Share by Application

8 India End-Stage Kidney Disease Treatment Sales, Revenue and Price
8.1 India End-Stage Kidney Disease Treatment Sales and Value (2014-2019)
8.1.1 India End-Stage Kidney Disease Treatment Sales Growth Rate (2014-2019)
8.1.2 India End-Stage Kidney Disease Treatment Revenue Growth Rate (2014-2019)
8.1.3 India End-Stage Kidney Disease Treatment Price Trend (2014-2019)
8.2 India End-Stage Kidney Disease Treatment Sales Market Share by Company
8.3 India End-Stage Kidney Disease Treatment Sales Market Share by Type
8.4 India End-Stage Kidney Disease Treatment Sales Market Share by Application

9 Company Profiles and Key Figures in End-Stage Kidney Disease Treatment Business
9.1 BLR Bio LLC
9.1.1 BLR Bio LLC End-Stage Kidney Disease Treatment Production Sites and Area Served
9.1.2 End-Stage Kidney Disease Treatment Specification and Application
9.1.3 BLR Bio LLC End-Stage Kidney Disease Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 CTI BioPharma Corp
9.2.1 CTI BioPharma Corp End-Stage Kidney Disease Treatment Production Sites and Area Served
9.2.2 End-Stage Kidney Disease Treatment Specification and Application
9.2.3 CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 F. Hoffmann-La Roche Ltd
9.3.1 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Production Sites and Area Served
9.3.2 End-Stage Kidney Disease Treatment Specification and Application
9.3.3 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Novartis AG
9.4.1 Novartis AG End-Stage Kidney Disease Treatment Production Sites and Area Served
9.4.2 End-Stage Kidney Disease Treatment Specification and Application
9.4.3 Novartis AG End-Stage Kidney Disease Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Prolong Pharmaceuticals LLC
9.5.1 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Production Sites and Area Served
9.5.2 End-Stage Kidney Disease Treatment Specification and Application
9.5.3 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 VESSL Therapeutics Ltd
9.6.1 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Production Sites and Area Served
9.6.2 End-Stage Kidney Disease Treatment Specification and Application
9.6.3 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
…

10 End-Stage Kidney Disease Treatment Maufacturing Cost Analysis
10.1 End-Stage Kidney Disease Treatment Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of End-Stage Kidney Disease Treatment
10.4 End-Stage Kidney Disease Treatment Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 End-Stage Kidney Disease Treatment Distributors List
11.3 End-Stage Kidney Disease Treatment Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 End-Stage Kidney Disease Treatment Market Forecast
13.1 Global End-Stage Kidney Disease Treatment Sales, Revenue and Price Forecast
13.1.1 Global End-Stage Kidney Disease Treatment Sales Growth Forecast (2019-2025)
13.1.2 Global End-Stage Kidney Disease Treatment Revenue Growth Forecast (2019-2025)
13.1.3 Global End-Stage Kidney Disease Treatment Price Trend Forecast (2019-2025)
13.2 Global End-Stage Kidney Disease Treatment Forecast by Region
13.2.1 Global End-Stage Kidney Disease Treatment Sales Growth Forecast by Region (2019-2025)
13.2.2 Global End-Stage Kidney Disease Treatment Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States End-Stage Kidney Disease Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe End-Stage Kidney Disease Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China End-Stage Kidney Disease Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan End-Stage Kidney Disease Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia End-Stage Kidney Disease Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India End-Stage Kidney Disease Treatment Sales, Revenue Growth Forecast (2019-2025)
13.3 Global End-Stage Kidney Disease Treatment Forecast by Type
13.3.1 Global End-Stage Kidney Disease Treatment Sales Forecast by Type (2019-2025)
13.3.2 Global End-Stage Kidney Disease Treatment Revenue Forecast by Type (2019-2025)
13.3.3 Global End-Stage Kidney Disease Treatment Price Forecast by Type (2019-2025)
13.4 Global End-Stage Kidney Disease Treatment Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

List of Tables and Figures

Market Breakdown by Region: End-Stage Kidney Disease Treatment Sales (K Pcs) and Value (Revenue: Million US$)
Market Breakdown by Type: End-Stage Kidney Disease Treatment Sales (K Pcs) and Revenue (Million US$)
Market Breakdown by Application: End-Stage Kidney Disease Treatment Sales (Jan)
Figure End-Stage Kidney Disease Treatment Product Picture
Table Global End-Stage Kidney Disease Treatment Sales (K Pcs) Growth Rate by Types (2014-2025)
Figure Global End-Stage Kidney Disease Treatment Sales Market Share by Types in 2018
Figure MK-3866 Product Picture
Figure Pacritinib Product Picture
Figure Sanguinate Product Picture
Figure Tesidolumab Product Picture
Figure Others Product Picture
Table Global End-Stage Kidney Disease Treatment Sales (K Pcs) Comparison by Application (2014-2025)
Figure Global Sales Market Share of End-Stage Kidney Disease Treatment by Application in 2018
Figure Clinic Examples
Figure Hospital Examples
Figure Others Examples
Table Global Market End-Stage Kidney Disease Treatment Revenue (Million USD) Comparison by Region 2014-2025
Figure United States End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure China End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure India End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global End-Stage Kidney Disease Treatment Sales (K Pcs) Growth Rate (2014-2025)
Figure Global End-Stage Kidney Disease Treatment Revenue (Million USD) Growth Rate (2014-2025)
Table Global End-Stage Kidney Disease Treatment Sales (K Pcs) of Key Companies (2014-2019)
Figure Global End-Stage Kidney Disease Treatment Sales by Company in 2018
Table Global End-Stage Kidney Disease Treatment Sales Share by Company (2014-2019)
Figure Global End-Stage Kidney Disease Treatment Sales Share by Company in 2018
Table Global End-Stage Kidney Disease Treatment Revenue (Million USD) by Company (2014-2019)
Figure Global End-Stage Kidney Disease Treatment Revenue (Million USD) by Company in 2018
Table Global End-Stage Kidney Disease Treatment Revenue Share by Company (2014-2019)
Figure Global End-Stage Kidney Disease Treatment Revenue Share by Company in 2018
Table Global End-Stage Kidney Disease Treatment Sales (K Pcs) Market Share by Region (2014-2019)
Table Global End-Stage Kidney Disease Treatment Sales Share by Region (2014-2019)
Figure Global End-Stage Kidney Disease Treatment Sales Share by Region in 2018
Table Global End-Stage Kidney Disease Treatment Revenue (Million USD) Market Share by Region (2014-2019)
Table Global End-Stage Kidney Disease Treatment Revenue Share by Region (2014-2019)
Figure Global End-Stage Kidney Disease Treatment Revenue Market Share by Region In 2018
Table Global End-Stage Kidney Disease Treatment Sales (K Pcs) by Type (2014-2019)
Table Global End-Stage Kidney Disease Treatment Sales Share by Type (2014-2019)
Figure Global End-Stage Kidney Disease Treatment Sales Growth Rate by Type in 2018
Table Global End-Stage Kidney Disease Treatment Revenue (Million USD) Market Share by Type (2014-2019)
Table Global End-Stage Kidney Disease Treatment Revenue Share by Type (2014-2019)
Figure Global End-Stage Kidney Disease Treatment Revenue Growth Rate by Type in 2018
Table Global End-Stage Kidney Disease Treatment Sales Market Share by Application (2014-2019)
Table Global End-Stage Kidney Disease Treatment Sales Share by Application (2014-2019)
Figure Global End-Stage Kidney Disease Treatment Sales Market Share by Application in 2018
Figure United States End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure United States End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure United States End-Stage Kidney Disease Treatment Price (USD/Pcs) Trend (2014-2019)
Table United States End-Stage Kidney Disease Treatment Sales (K Pcs) by Company (2014-2019)
Table United States End-Stage Kidney Disease Treatment Sales Market Share by Company (2014-2019)
Figure United States End-Stage Kidney Disease Treatment Sales Market Share by Company in 2018
Table United States End-Stage Kidney Disease Treatment Sales (K Pcs) by Type (2014-2019)
Table United States End-Stage Kidney Disease Treatment Sales Market Share by Type (2014-2019)
Figure United States End-Stage Kidney Disease Treatment Sales Market Share by Type in 2018
Table United States End-Stage Kidney Disease Treatment Sales (K Pcs) by Application (2014-2019)
Table United States End-Stage Kidney Disease Treatment Sales Market Share by Application (2014-2019)
Figure United States End-Stage Kidney Disease Treatment Sales Market Share by Application in 2018
Figure Europe End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure Europe End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Europe End-Stage Kidney Disease Treatment Price (USD/Pcs) Trend (2014-2019)
Table Europe End-Stage Kidney Disease Treatment Sales (K Pcs) by Company (2014-2019)
Table Europe End-Stage Kidney Disease Treatment Sales Market Share by Company (2014-2019)
Figure Europe End-Stage Kidney Disease Treatment Sales Market Share by Company in 2018
Table Europe End-Stage Kidney Disease Treatment Sales (K Pcs) by Type (2014-2019)
Table Europe End-Stage Kidney Disease Treatment Sales Market Share by Type (2014-2019)
Figure Europe End-Stage Kidney Disease Treatment Sales Market Share by Type in 2018
Table Europe End-Stage Kidney Disease Treatment Sales (K Pcs) by Application (2014-2019)
Table Europe End-Stage Kidney Disease Treatment Sales Market Share by Application (2014-2019)
Figure Europe End-Stage Kidney Disease Treatment Sales Market Share by Application in 2018
Figure China End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure China End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure China End-Stage Kidney Disease Treatment Price (USD/Pcs) Trend (2014-2019)
Table China End-Stage Kidney Disease Treatment Sales (K Pcs) by Company (2014-2019)
Table China End-Stage Kidney Disease Treatment Sales Market Share by Company (2014-2019)
Figure China End-Stage Kidney Disease Treatment Sales Market Share by Company in 2018
Table China End-Stage Kidney Disease Treatment Sales (K Pcs) by Type (2014-2019)
Table China End-Stage Kidney Disease Treatment Sales Market Share by Type (2014-2019)
Figure China End-Stage Kidney Disease Treatment Sales Market Share by Type in 2018
Table China End-Stage Kidney Disease Treatment Sales (K Pcs) by Application (2014-2019)
Table China End-Stage Kidney Disease Treatment Sales Market Share by Application (2014-2019)
Figure China End-Stage Kidney Disease Treatment Sales Market Share by Application in 2018
Figure Japan End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure Japan End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Japan End-Stage Kidney Disease Treatment Price (USD/Pcs) Trend (2014-2019)
Table Japan End-Stage Kidney Disease Treatment Sales (K Pcs) by Company (2014-2019)
Table Japan End-Stage Kidney Disease Treatment Sales Market Share by Company (2014-2019)
Figure Japan End-Stage Kidney Disease Treatment Sales Market Share by Company in 2018
Table Japan End-Stage Kidney Disease Treatment Sales (K Pcs) by Type (2014-2019)
Table Japan End-Stage Kidney Disease Treatment Sales Market Share by Type (2014-2019)
Figure Japan End-Stage Kidney Disease Treatment Sales Market Share by Type in 2018
Table Japan End-Stage Kidney Disease Treatment Sales (K Pcs) by Application (2014-2019)
Table Japan End-Stage Kidney Disease Treatment Sales Market Share by Application (2014-2019)
Figure Japan End-Stage Kidney Disease Treatment Sales Market Share by Application in 2018
Figure Southeast Asia End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure Southeast Asia End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Southeast Asia End-Stage Kidney Disease Treatment Price (USD/Pcs) Trend (2014-2019)
Table Southeast Asia End-Stage Kidney Disease Treatment Sales (K Pcs) by Company (2014-2019)
Table Southeast Asia End-Stage Kidney Disease Treatment Sales Market Share by Company (2014-2019)
Figure Southeast Asia End-Stage Kidney Disease Treatment Sales Market Share by Company in 2018
Table Southeast Asia End-Stage Kidney Disease Treatment Sales (K Pcs) by Type (2014-2019)
Table Southeast Asia End-Stage Kidney Disease Treatment Sales Market Share by Type (2014-2019)
Figure Southeast Asia End-Stage Kidney Disease Treatment Sales Market Share by Type in 2018
Table Southeast Asia End-Stage Kidney Disease Treatment Sales (K Pcs) by Application (2014-2019)
Table Southeast Asia End-Stage Kidney Disease Treatment Sales Market Share by Application (2014-2019)
Figure Southeast Asia End-Stage Kidney Disease Treatment Sales Market Share by Application in 2018
Figure India End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure India End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure India End-Stage Kidney Disease Treatment Price (USD/Pcs) Trend (2014-2019)
Table India End-Stage Kidney Disease Treatment Sales (K Pcs) by Company (2014-2019)
Table India End-Stage Kidney Disease Treatment Sales Market Share by Company (2014-2019)
Figure India End-Stage Kidney Disease Treatment Sales Market Share by Company in 2018
Table India End-Stage Kidney Disease Treatment Sales (K Pcs) by Type (2014-2019)
Table India End-Stage Kidney Disease Treatment Sales Market Share by Type (2014-2019)
Figure India End-Stage Kidney Disease Treatment Sales Market Share by Type in 2018
Table India End-Stage Kidney Disease Treatment Sales (K Pcs) by Application (2014-2019)
Table India End-Stage Kidney Disease Treatment Sales Market Share by Application (2014-2019)
Figure India End-Stage Kidney Disease Treatment Sales Market Share by Application in 2018
Table BLR Bio LLC End-Stage Kidney Disease Treatment Production Sites and Area Served
Table BLR Bio LLC End-Stage Kidney Disease Treatment Specification and Application
Table BLR Bio LLC End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure BLR Bio LLC End-Stage Kidney Disease Treatment Sales Growth Rate (2014-2019)
Figure BLR Bio LLC End-Stage Kidney Disease Treatment Revenue Share in International Market (2014-2019)
Figure BLR Bio LLC End-Stage Kidney Disease Treatment Main Business and Markets Served
Table CTI BioPharma Corp End-Stage Kidney Disease Treatment Production Sites and Area Served
Table CTI BioPharma Corp End-Stage Kidney Disease Treatment Specification and Application
Table CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales Growth Rate (2014-2019)
Figure CTI BioPharma Corp End-Stage Kidney Disease Treatment Revenue Share in International Market (2014-2019)
Figure CTI BioPharma Corp End-Stage Kidney Disease Treatment Main Business and Markets Served
Table F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Production Sites and Area Served
Table F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Specification and Application
Table F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales Growth Rate (2014-2019)
Figure F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Revenue Share in International Market (2014-2019)
Figure F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Main Business and Markets Served
Table Novartis AG End-Stage Kidney Disease Treatment Production Sites and Area Served
Table Novartis AG End-Stage Kidney Disease Treatment Specification and Application
Table Novartis AG End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Novartis AG End-Stage Kidney Disease Treatment Sales Growth Rate (2014-2019)
Figure Novartis AG End-Stage Kidney Disease Treatment Revenue Share in International Market (2014-2019)
Figure Novartis AG End-Stage Kidney Disease Treatment Main Business and Markets Served
Table Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Production Sites and Area Served
Table Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Specification and Application
Table Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales Growth Rate (2014-2019)
Figure Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Revenue Share in International Market (2014-2019)
Figure Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Main Business and Markets Served
Table VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Production Sites and Area Served
Table VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Specification and Application
Table VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales Growth Rate (2014-2019)
Figure VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Revenue Share in International Market (2014-2019)
Figure VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Key Raw Materials Price Trend
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of End-Stage Kidney Disease Treatment
Figure Manufacturing Process Analysis of End-Stage Kidney Disease Treatment
Figure End-Stage Kidney Disease Treatment Industrial Chain Analysis
Table End-Stage Kidney Disease Treatment Distributors List
Table End-Stage Kidney Disease Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Global End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global End-Stage Kidney Disease Treatment Price (USD/Pcs) and Trend Forecast (2019-2025)
Table Global End-Stage Kidney Disease Treatment Sales (K Pcs) Forecast by Regions (2019-2025)
Figure Global End-Stage Kidney Disease Treatment Sales Market Share Forecast by Regions (2019-2025)
Figure Global End-Stage Kidney Disease Treatment Sales Market Share Forecast by Regions in 2025
Table Global End-Stage Kidney Disease Treatment Revenue (Million USD) Forecast by Regions (2019-2025)
Figure Global End-Stage Kidney Disease Treatment Revenue Market Share Forecast by Regions (2019-2025)
Figure Global End-Stage Kidney Disease Treatment Revenue Market Share Forecast by Regions in 2025
Figure United States End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure United States End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Europe End-Stage Kidney Disease Treatment Revenue and Growth Rate Forecast (2019-2025)
Figure China End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure China End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Japan End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure India End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure India End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global End-Stage Kidney Disease Treatment Sales (K Pcs) Forecast by Type (2019-2025)
Figure Global End-Stage Kidney Disease Treatment Sales Market Share Forecast by Type (2019-2025)
Table Global End-Stage Kidney Disease Treatment Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global End-Stage Kidney Disease Treatment Revenue Market Share Forecast by Type (2019-2025)
Table Global End-Stage Kidney Disease Treatment Price (USD/Pcs) Forecast by Type (2019-2025)
Table Global End-Stage Kidney Disease Treatment Sales (K Pcs) Forecast by Application (2019-2025)
Figure Global End-Stage Kidney Disease Treatment Sales Market Share Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界のハンチントン病タンパク質市場2019

Global Huntington Disease Protein Sales Market Report 2019
QYR9N1730 2019年6月10日 103Pages
本調査レポートでは、ハンチントン病タンパク質の世界市場について調査・分析し、ハンチントン病タンパク質のメーカー別販売量、市場シェア分析、種類別販売分析（NI-302
、NLF-HD
、P-301905
、IONIS-HTTRx
、その他）、用途別販売分...

世界の変性椎間板疾患の治療法市場2019

Global Degenerative Disc Disease Threpeutics Sales Market Report 2019
QYR9N0266 2019年6月10日 107Pages
本調査レポートでは、変性椎間板疾患の治療法の世界市場について調査・分析し、変性椎間板疾患の治療法のメーカー別販売量、市場シェア分析、種類別販売分析（ALLOB
、AMG-0101
、BRTX-100
、OTICR-01
、その他）、用途別販売分析（診療...

世界の家族性腺腫性ポリポーシス治療市場2019

Global Familial Adenomatous Polyposis Treatment Sales Market Report 2019
QYR9N0916 2019年6月10日 100Pages
本調査レポートでは、家族性腺腫性ポリポーシス治療の世界市場について調査・分析し、家族性腺腫性ポリポーシス治療のメーカー別販売量、市場シェア分析、種類別販売分析（イコサペント、塩酸エルフロニチン、アスピリン、CEQ-508、その他）、用途別販売分析（診療所、病院、その他）、地域別販売分析（米国、ヨーロ...

世界の病気のリスクと健康に関するDNA検査市場2019

Global Disease Risk and Health DNA Test Sales Market Report 2019
QYR9N0466 2019年6月10日 126Pages
本調査レポートでは、病気のリスクと健康に関するDNA検査の世界市場について調査・分析し、病気のリスクと健康に関するDNA検査のメーカー別販売量、市場シェア分析、種類別販売分析（セリアック病、パーキンソン病、アルツハイマー病、その他）、用途別販売分析（オンライン、オフライン）、地域別販売分析（米国、ヨ...

世界のホモ接合型家族性高コレステロール血症の治療市場2019

Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Report 2019
QYR9N1684 2019年6月10日 107Pages
本調査レポートでは、ホモ接合型家族性高コレステロール血症の治療の世界市場について調査・分析し、ホモ接合型家族性高コレステロール血症の治療のメーカー別販売量、市場シェア分析、種類別販売分析（AEM-2802、AEM-2814、アリロクマブ、エビナクマブ、その他）、用途別販売分析（診療所、病院、その他）...

世界の消費者向け疾病リスクと健康DNA検査市場2019

Global Direct-to-consumer Disease Risk and Health DNA Test Sales Market Report 2019
QYR9N0459 2019年6月10日 124Pages
本調査レポートでは、消費者向け疾病リスクと健康DNA検査の世界市場について調査・分析し、消費者向け疾病リスクと健康DNA検査のメーカー別販売量、市場シェア分析、種類別販売分析（タイプI、セリアック病、パーキンソン病、アルツハイマー病、その他）、用途別販売分析（オンライン、オフライン）、地域別販売分析...

世界の消費者向け疾病リスクと健康遺伝子検査市場2019

Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Report 2019
QYR9N0460 2019年6月10日 129Pages
本調査レポートでは、消費者向け疾病リスクと健康遺伝子検査の世界市場について調査・分析し、消費者向け疾病リスクと健康遺伝子検査のメーカー別販売量、市場シェア分析、種類別販売分析（セリアック病、パーキンソン病、アルツハイマー病、その他）、用途別販売分析（オンライン、オフライン）、地域別販売分析（米国、ヨ...

世界のフェイシャルトリートメントマスク市場2019

Global Facial Treatment Mask Sales Market Report 2019
QYR9N0913 2019年6月10日 114Pages
本調査レポートでは、フェイシャルトリートメントマスクの世界市場について調査・分析し、フェイシャルトリートメントマスクのメーカー別販売量、市場シェア分析、種類別販売分析（フレークマスク、ペーストマスク）、用途別販売分析（スペシャリスト小売業者、ファクトリーアウトレット、インターネットセールス、その他）...

世界のヒューム処理プラント（FTP）市場2019

Global Fume Treatment Plant (FTP) Sales Market Report 2019
QYR9N1202 2019年6月10日 107Pages
本調査レポートでは、ヒューム処理プラント（FTP）の世界市場について調査・分析し、ヒューム処理プラント（FTP）のメーカー別販売量、市場シェア分析、種類別販売分析（ダイカスト、鍛造、熱処理、その他）、用途別販売分析（鉄鋼業、セメント、レンガ産業、化学工業、その他）、地域別販売分析（米国、ヨーロッパ、...

世界の女性のストレス尿失禁治療装置市場2019

Global Female Stress Urinary Incontinence Treatment Devices Sales Market Report 2019
QYR9N0943 2019年6月10日 101Pages
本調査レポートでは、女性のストレス尿失禁治療装置の世界市場について調査・分析し、女性のストレス尿失禁治療装置のメーカー別販売量、市場シェア分析、種類別販売分析（シリコーン、ポリウレタンフォーム）、用途別販売分析（婦人科クリニック、病院、外来手術センター）、地域別販売分析（米国、ヨーロッパ、中国、日本...

世界のハンチントン病タンパク質市場2019 The global Huntington Disease Protein market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Huntington Disease Protein market status and forecast, categorizes the global Huntington Disease Protein…
世界の変性椎間板疾患の治療法市場2019 The global Degenerative Disc Disease Threpeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Degenerative Disc Disease Threpeutics market status and forecast, categorizes the global Dege…
世界の病気のリスクと健康に関するDNA検査市場2019 The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrie…
世界の消費者向け疾病リスクと健康DNA検査市場2019 The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrie…
世界の消費者向け疾病リスクと健康遺伝子検査市場2019 The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrie…